Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices 3567 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Cancer Biomarkers Study Section. 

Date: February 24–25, 2022. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lawrence Ka-Yun Ng, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6152, 

MSC 7804, Bethesda, MD 20892, 301–357– 

9318, ngkl@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Immunology B Integrated Review Group; 

Hypersensitivity, Autoimmune, and Immunemediated Diseases Study Section. 

Date: February 24–25, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Deborah Hodge, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4207, 

MSC 7812, Bethesda, MD 20892, (301) 435– 

1238, hodged@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 18, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–01243 Filed 1–21–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Emerging Science and 

Technology in Transplantation Research 

(U01 Clinical Trial Not Allowed). 

Date: February 16–17, 2022. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G45, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Vanitha S. Raman, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G45, Rockville, MD 

20852, 301–761–7949, vanitha.raman@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 18, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–01240 Filed 1–21–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel; Clinical Studies. 

Date: February 23, 2022. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institute of Dental and 

Craniofacial Research, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Yun Mei, MD Scientific 

Review Officer, Scientific Review Branch, 

Natl Institute of Dental and Craniofacial 

Research, National Institutes of Health, 6701 

Democracy Boulevard, Suite #670, Bethesda, 

MD 20892, (301) 827–4639, yun.mei@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: January 18, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–01201 Filed 1–21–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2022–0001] 

Notice Seeking Public Comments on 

Methods To Prevent the Importation of 

Goods Mined, Produced, or 

Manufactured With Forced Labor in the 

People’s Republic of China, Especially 

in the Xinjiang Uyghur Autonomous 

Region, Into the United States 

AGENCY: Department of Homeland 

Security. 

ACTION: Request for public comments. 

SUMMARY: The U.S. Department of 

Homeland Security, on behalf of the 

Forced Labor Enforcement Task Force 

(FLETF), is seeking comments from the 

public, as required by the Uyghur 

Forced Labor Prevention Act, on how 

best to ensure that goods, wares, 

articles, and merchandise mined, 

produced, or manufactured wholly or in 

part with forced labor in the People’s 

Republic of China are not imported into 

the United States. Such goods, wares, 

articles and merchandise include those 

mined, produced, or manufactured 

wholly or in part with forced labor by 

Uyghurs, Kazakhs, Kyrgyz, Tibetans, 

and members of other persecuted groups 

in the People’s Republic of China, and 

especially in the Xinjiang Uyghur 

Autonomous Region. After receiving 

comments, the FLETF will conduct a 

public hearing and develop a strategy 

for supporting enforcement of section 

307 of the Tariff Act of 1930, as 

amended. 

DATES: Comments must be received on 

or before March 10, 2022 at 11:59 p.m. 

EST. 

ADDRESSES: You may submit comments 

on this notice, identified by Docket No. 

DHS–2022–0001, through the Federal eRulemaking Portal at https://

www.regulations.gov. Follow the 

website instructions for submitting 

comments. 


jspears on DSK121TN23PROD with NOTICES1